targetspecif
therapi
discov
inventor
chemotherapi
paul
ehrlich
ensu
develop
hybridoma
technolog
gener
monoclon
antibodi
realiz
ehrlich
vision
along
therapeut
success
antibodi
led
develop
number
novel
antibodi
drug
exampl
drug
includ
trastuzumab
target
receptor
tyrosineprotein
kinas
implic
ovarian
breast
tumor
chimer
mab
rituximab
develop
treat
bcell
nonhodgkin
lymphoma
vedolizumab
inhibit
integrin
play
import
role
ulcer
coliti
crohn
diseas
idea
use
nucleic
acid
recogn
protein
target
emerg
later
result
hiv
research
shown
transact
respons
element
tar
contain
rna
sequenc
inhibit
hiv
replic
high
affin
specif
aptam
short
singlestrand
oligonucleotid
dna
rna
bind
target
high
affin
specif
fold
tertiari
structur
aptam
extens
use
basic
research
ensur
food
safeti
monitor
environ
furthermor
aptam
promis
role
clinic
diagnost
therapeut
agent
although
aptam
recogn
bind
target
interest
like
antibodi
number
advantag
shorter
gener
time
lower
cost
manufactur
batchtobatch
variabl
higher
modifi
better
thermal
stabil
higher
target
potenti
rang
ion
live
anim
tabl
thorough
comparison
aptam
antibodi
review
zhou
rossi
review
provid
updat
recent
advanc
field
aptam
particular
focu
method
gener
novel
aptam
applic
aptam
biosens
biotechnolog
biomedicin
selex
standard
method
gener
aptam
target
interest
first
incub
pool
singlestrand
random
oligonucleotid
oligonucleotid
selex
librari
typic
consist
nucleotid
harbor
random
region
middl
fix
sequenc
end
subsequ
targetbind
oligonucleotid
separ
unbound
one
bound
dna
oligom
elut
amplifi
pcr
sever
round
select
result
dna
sequenc
aptam
high
affin
specif
enrich
pool
sequenc
figur
common
modif
toward
tradit
selex
method
aim
simplifi
selex
procedur
gener
improv
aptam
includ
chang
bind
condit
platform
select
perform
type
target
librari
design
immobil
matrix
besid
dna
librari
rna
librari
also
success
use
selex
differ
major
rna
selex
protocol
compar
dna
selex
includ
requir
protect
rna
rnaas
amplif
rna
polymeras
revers
transcript
step
pcr
consequ
use
rna
selex
usual
encod
promot
rna
polymeras
affin
specif
aptam
larg
depend
target
threedimension
structur
threedimension
target
artifici
recombin
protein
differ
nativ
conform
suggest
vitro
select
aptam
might
best
approach
select
aptam
highest
affin
specif
standard
physiolog
condit
ipselex
develop
address
issu
although
ipselex
compar
tradit
selex
method
includ
immunoprecipit
step
pull
desir
target
nativ
form
lead
enrich
aptam
retain
abil
recogn
protein
normal
physiolog
condit
first
round
ipselex
select
cell
harbor
protein
interest
incub
ssdna
librari
suitabl
buffer
condit
subsequ
cell
lyse
target
protein
immunoprecipit
use
antibodyco
bead
follow
sever
round
wash
proteinaptam
complex
elut
bead
dna
sequenc
pcr
amplifi
next
round
select
process
select
oligonucleotid
high
specif
affin
desir
target
repeat
thu
lead
final
enrich
aptam
pool
select
aptam
identifi
sequenc
ipselex
success
use
identif
aptam
comparison
selex
method
requir
immobil
target
solid
surfac
captureselex
use
solubl
small
molecul
target
captureselex
util
special
dna
librari
harbor
fix
domain
center
flank
two
random
domain
flank
primerbind
sequenc
fix
domain
center
design
complementari
biotinyl
antisens
oligonucleotid
allow
immobil
dna
librari
onto
avidinco
bead
hybrid
aptam
abl
form
complex
target
detach
bead
solubil
allow
collect
pcr
amplif
captureselex
strategi
use
success
select
dna
rna
aptam
small
organ
molecul
solut
furthermor
captureselex
use
recent
select
aptam
furaneol
penicillin
fluoroquinolon
antibiot
tobramycin
aminoglycosid
antibiot
cellselex
live
cell
use
select
aptam
cellselex
consid
practic
applic
particularli
oncolog
approach
select
aptam
specif
cancer
cell
target
employ
cellselex
aptamerbas
probe
develop
number
cancer
includ
cervic
cancer
ovarian
cancer
liver
cancer
prostat
cancer
breast
cancer
glioma
colorect
carcinoma
lung
carcinoma
number
cellselex
variant
develop
last
year
includ
cellintern
selex
aptam
transport
intracellularli
intern
analyz
cell
cellselex
involv
develop
laboratori
cell
cultur
develop
aptam
crossov
selex
util
cell
purifi
protein
increas
select
effici
tabl
ligandguid
select
lig
anoth
interest
variant
cellselex
select
aptam
specif
bind
known
cell
surfac
protein
lig
therefor
particularli
use
gener
aptam
high
specif
util
also
select
aptam
high
specif
membranebound
immunoglobulin
migm
furthermor
flow
cytometri
success
integr
cellselex
approach
isol
aptamerbound
cell
elimin
dead
cell
main
disadvantag
cellselex
variant
whole
process
time
consum
requir
certain
level
technic
expertis
tabl
main
advantag
cellselex
variant
abund
molecul
cell
surfac
potenti
becom
target
nativ
conform
import
diagnost
therapeut
applic
furthermor
whole
cell
appli
select
need
prior
knowledg
biomark
cellselex
success
select
lead
gener
aptam
unknown
biomark
subsequ
identifi
purif
analysi
aptam
tabl
ceselex
exploit
capillari
electrophoresi
analyt
techniqu
separ
ion
base
electrophoret
mobil
gener
aptam
high
affin
specif
one
four
round
select
compar
select
round
requir
tradit
selex
capillari
electrophoresi
ceselex
separ
bound
dna
molecul
unbound
one
solut
thu
elimin
linker
kinet
bia
stationari
support
prepar
wash
ceselex
first
use
gener
aptam
neuropeptid
ige
number
aptam
success
gener
employ
ceselex
includ
alphafetoprotein
activ
protein
c
furthermor
fraction
collect
approach
integr
ceselex
partit
bound
complex
order
gener
target
specif
bind
aptam
singl
round
select
recent
ceselex
success
use
gener
aptam
tumor
biomark
earli
diagnosi
hepatocellular
carcinoma
howev
capillari
electrophoresi
restrict
select
high
molecular
weight
target
addit
divers
librari
handl
ceselex
larg
reduc
compar
selex
tabl
mselex
base
microfluid
system
capabl
handl
small
volum
fluid
employ
obtain
high
affin
aptam
divers
protein
target
recent
includ
influenza
nucleoprotein
infa
np
ovarian
cancer
cardiovascular
biomark
mselex
univers
automat
approach
rapid
gener
aptam
high
affin
specif
microscal
level
notabl
improv
mselex
includ
micromagnet
separ
devic
increas
effici
separ
solgel
techniqu
beadbas
acoustophoresi
techniqu
microarrayintegr
microfluid
chip
techniqu
afmselex
exploit
high
resolut
atom
forc
microscopi
afm
cantilev
probe
measur
weak
forc
sampl
surfac
probe
creat
threedimension
imag
sampl
surfac
afmselex
approach
util
afm
dynam
affin
forc
measur
develop
recent
obtain
aptam
increas
affin
furthermor
afmselex
also
success
appli
develop
aptam
human
serum
albumin
recent
studi
aptam
human
serum
albumin
could
select
fourth
round
base
measur
dnaduplex
interact
afm
aegisselex
util
modifi
librari
artifici
expand
genet
code
includ
incorpor
hydrophob
base
imidazo
pyridin
ds
nucleotid
random
natur
nucleotid
sequenc
librari
obtain
aptam
increas
affin
aegisselex
also
use
incorpor
four
natur
two
synthet
nucleotid
commonli
refer
p
z
rearrang
donor
acceptor
hydrogen
bond
nucleobas
incorpor
unnatur
base
pair
shown
significantli
increas
function
divers
aptam
furthermor
aegisselex
use
success
laboratori
evolut
artifici
expand
dna
gener
aptam
target
toxic
form
bacillu
anthraci
protect
antigen
current
applic
aegisselex
limit
mainli
poor
recognit
unnatur
base
natur
occur
dna
polymeras
howev
obstacl
overcom
direct
evolut
polymeras
abl
recogn
unnatur
base
whole
anim
vivo
selex
mous
cancer
model
pathogeninfect
mice
serv
posit
target
aptam
librari
first
inject
target
mice
figur
follow
inocul
organ
interest
harvest
figur
next
select
aptam
isol
amplifi
pcr
figur
select
counter
select
introduc
inocul
aptam
pool
healthi
mous
tissu
figur
result
sequenc
diseasespecif
aptam
high
affin
specif
target
tissu
enrich
identifi
sequenc
figur
aptam
penetr
barrier
bbb
success
develop
use
select
strategi
brain
tissu
mice
animalselex
employ
recent
identifi
bone
target
aptam
mous
model
prostat
cancer
bone
metastasi
tolllik
receptor
block
aptam
use
acut
stroke
treatment
aptam
potenti
use
biomark
neurolog
disord
furthermor
animalselex
murin
model
lymphoma
use
recent
screen
dna
aptam
home
specif
lymphoma
bone
marrow
involv
fluoresc
reson
energi
transfer
fret
aptam
develop
novel
highthroughput
screen
tool
escherichia
coli
outer
membran
protein
detect
enterotoxaemia
e
coli
etec
furthermor
aptam
util
detect
surfac
protein
campylobact
jejuni
addit
use
purifi
bacteri
protein
target
whole
bacteriumbas
selex
procedur
appli
detect
e
coli
lactobacillu
acidophilu
staphylococcu
aureu
virul
strain
mycobacterium
tuberculosi
vibrio
parahemolyticu
shigella
sonnei
c
jejuni
led
develop
aptam
increas
affin
specif
selexbas
approach
also
use
gener
molecular
probe
detect
viral
infect
vaccinia
viru
herp
simplex
viru
hepat
c
viru
hepat
b
viru
human
immunodefici
viru
influenza
viru
sever
acut
respiratori
syndrom
sar
coronaviru
furthermor
selex
use
success
gener
aptam
detect
number
parasit
trypanosoma
spp
leishmania
spp
plasmodium
spp
cryptosporidium
parvum
entamoeba
histolytica
thorough
overview
recent
advanc
aptam
diagnost
protozoan
parasit
review
ospinavilla
et
al
develop
aptam
reliabl
time
cancer
diagnosi
prognosi
evalu
highest
import
address
issu
aptam
develop
detect
number
cancerrel
biomark
includ
multipl
tumorrel
protein
live
cancer
cell
mucin
human
epiderm
growth
factor
receptor
estrogen
receptor
aptam
detect
breast
cancer
cell
leukemia
ccrfcem
cell
also
develop
recent
addit
aptam
success
use
detect
number
tumorrel
solubl
biomark
includ
carcinoembryon
antigen
cea
prostat
specif
antigen
psa
fluoresc
label
aptam
show
high
detect
rate
metastat
tumor
tissu
furthermor
aptam
success
use
also
vivo
imag
lymphoma
adenocarcinoma
leukemia
glioblastoma
cancer
type
current
develop
applic
aptam
molecular
recognit
cancer
summar
recent
review
sun
et
al
progress
develop
aptam
stem
cell
slow
aptam
stem
cell
marker
cancer
stem
cell
csc
includ
cancer
cell
surfac
biomark
epitheli
cell
adhes
molecul
epcam
mous
embryon
stem
cell
aptam
potenti
monitor
minim
environment
pollut
result
ill
antibiot
heavi
metal
toxin
pathogen
toxic
nervou
endocrin
reproduct
system
antibiot
use
farm
anim
may
accumul
anim
tissu
transmit
human
upon
ingest
address
issu
aptam
develop
antibiot
chloramphenicol
tetracyclin
furthermor
aptam
number
environment
toxin
develop
recent
includ
aptam
ochratoxin
ota
bacteri
endotoxin
bisphenol
aptam
mercuri
arsen
copper
lead
also
gener
identifi
heavi
metal
contamin
aptam
detect
variou
pesticid
environ
also
develop
recent
fungicid
carbendazim
acetamiprid
atrazin
chlorpyripho
addit
aptam
gener
variou
type
herbicid
insecticid
may
caus
reproduct
damag
human
abraham
et
al
report
identif
character
ssdna
aptam
herbicid
atrazin
recent
eas
differ
aptam
structur
gener
togeth
abil
bind
specif
target
form
stabl
tertiari
structur
led
widespread
applic
aptam
biosensor
figur
besid
monitor
environment
contamin
describ
exampl
recent
develop
biosensor
includ
follow
aptamerbas
biosensor
target
diseas
biomark
plateletderiv
growth
factor
bb
pdgfbb
cancer
relat
protein
help
earli
diagnosi
prognosi
cancer
develop
biosensor
azol
class
antifung
drug
applic
therapeut
drug
monitor
patient
invas
fungal
infect
biosensor
harbor
dna
aptam
target
blactoglobulin
detect
milk
allergen
highli
sensit
biosensor
detect
human
epiderm
growth
factor
receptor
applic
realtim
detect
breast
cancer
cell
biosensor
detect
bisphenol
biosensor
enhanc
use
differ
nanomateri
figur
good
exampl
graphenebas
biosensor
target
bglobulin
detect
milk
allergen
biosensor
detect
human
epiderm
growth
factor
receptor
describ
latter
ultrafin
graphen
nanomesh
continu
graphen
nanostructur
high
densiti
hole
punch
basal
plane
creat
improv
signal
onoff
ratio
biosensor
enhanc
use
biomateri
antibodi
form
sandwich
structur
biosensor
develop
wiedman
et
al
azol
class
antifung
drug
two
aptam
combin
form
sandwich
structur
current
chang
biosensor
electr
signal
current
resist
upon
bind
analyt
major
principl
detect
electrochem
imped
spectroscopi
ei
cyclic
voltammetri
cv
usual
use
monitor
complex
occur
electrod
surfac
dnabas
electrochem
biosensor
wide
use
detect
heavi
metal
ion
includ
mercuri
lead
copper
fluorescencelabel
aptam
probe
also
wide
use
biosensor
figur
novel
labelfre
aptasensor
acetamiprid
fluoresc
reson
energi
transfer
fret
involv
conform
chang
take
place
aptam
bind
acetamiprid
effect
stabil
gold
nanoparticl
solut
biosensor
dualcolor
au
nc
gold
nanoclust
excit
singlewavelength
excit
use
energi
donor
achiev
simultan
detect
multipl
tumor
marker
anoth
recent
exampl
fluoresc
biosensor
biosensor
detect
bisphenol
base
adsorpt
abil
nanos
iron
framework
dna
aptam
enhanc
affin
detect
recent
studi
focus
three
aspect
reconstruct
aptam
modifi
electrod
exploit
intersubst
interact
demonstr
remov
nonbind
domain
aptam
could
increas
bind
affin
specif
aptamertarget
complex
improv
densiti
bind
domain
furthermor
roll
circl
amplif
increas
length
aptam
thu
increas
number
bind
domain
electrochem
roughen
approach
also
enhanc
signal
electrochem
sensor
increas
microscop
surfac
area
gold
electrod
simpl
method
requir
pretreat
compar
convent
electrochem
deposit
increas
electrod
surfac
signal
amplif
also
achiev
via
synerget
catalysi
use
dnazymedecor
aupd
nanoparticl
signal
amplifi
synergist
catalysi
gquadruplexheminhrpaupdpoli
ophenylenediamin
bioconjug
thu
greatli
enhanc
sensit
biosensor
jeddi
saiz
present
first
approach
predict
threedimension
structur
aptam
sequenc
focus
explicitli
ssdna
hairpin
differ
aptam
configur
result
differ
affin
thu
highlight
role
configur
aptam
sensit
specif
reliabl
due
abil
compet
small
molecul
protein
ligand
inhibit
target
aptam
consid
promis
therapeut
furthermor
aptam
activ
function
target
receptor
act
carrier
deliveri
therapeut
agent
target
cell
tissu
exampl
aptam
potenti
act
antivir
agent
previou
work
suggest
rna
aptam
synthet
deriv
neutral
furthermor
rna
aptam
rigi
inhibit
newcastl
diseas
viru
ndv
vesicular
stomat
viru
vsv
influenza
viru
replic
rna
aptam
abl
effici
inhibit
proteas
helicas
activ
develop
target
hepat
c
viru
hcv
helicas
domain
thu
inhibit
hcv
aptam
discoveri
preclin
stage
includ
target
cancer
bind
differ
growth
factor
eg
vegf
bfgf
pdgf
kgf
rna
aptam
bind
chemokin
ligand
dna
aptam
target
vimentin
involv
maintain
cell
shape
cytoplasm
integr
cytoskeleton
stabil
furthermor
aptam
discoveri
preclin
stage
includ
bacteri
infect
caus
e
coli
aureu
tuberculosi
salmonella
spp
number
aptam
immun
disord
preclin
stage
includ
ssdna
aptam
target
autoantibodi
furthermor
aptam
preclin
stage
develop
includ
target
neurodegen
diseas
immun
disord
inflamm
number
aptam
enter
clinic
trial
ocular
diseas
haematolog
diseas
cancer
pegaptanib
vascular
endotheli
growth
factor
vegf
specif
aptam
approv
therapeut
use
agerel
macular
degener
pegaptanib
block
vegf
play
key
role
patholog
angiogenesi
exampl
ocular
neovascular
diseas
agerel
macular
degener
amd
diabet
macular
oedema
grich
dna
aptam
nucleolin
undergo
phase
ii
clinic
trial
acut
myeloid
leukemia
antitumor
activ
stem
abil
bind
cell
surfac
nucleolin
therebi
inhibit
dna
synthesi
prevent
cell
growth
signal
induc
apoptosi
shown
effici
varieti
cancer
cell
includ
lung
cancer
colorect
cancer
breast
cancer
hepatocellular
carcinoma
lrna
aptam
chemokin
cc
motif
ligand
phase
clinic
trial
type
diabet
diabet
nephropathi
bind
neutral
human
chemokin
relat
chemokin
prevent
infiltr
proinflammatori
cell
kidney
allow
resolv
exist
inflamm
time
aptam
therapeut
includ
clinic
trial
summar
tabl
current
list
therapeut
aptam
clinic
trial
constantli
updat
found
clinic
trial
websit
nih
us
nation
librari
medicin
http
clinicaltrialsgov
recent
review
ismail
alshaer
aptam
use
success
deliveri
varieti
therapeut
reagent
target
cell
tissu
aptamerbas
deliveri
system
includ
aptamertherapeut
oligonucleotid
conjug
aptamerdrug
conjug
aptamerdecor
nanomateri
exampl
aptam
use
target
drug
deliveri
shown
tabl
describ
review
aptam
number
biotechnolog
medicallyrelev
applic
howev
main
limit
vivo
therapeut
applic
target
specif
deliveri
cellselex
whole
anim
vivo
selex
employ
address
issu
target
sitespecif
deliveri
crucial
problem
therapeut
use
oligonucleotid
overcom
employ
aptam
form
nanorocket
aptamerteth
multistag
nanorocket
complex
two
aptam
contain
function
oligonucleotid
serial
stage
aptam
mount
top
anoth
build
carrier
nanorocket
payload
drug
allow
deliveri
select
tissu
cell
type
even
subcellular
organel
figur
design
engin
multistag
nanorocket
whole
animalselex
tissueselex
cellselex
fractionationselex
use
involv
select
oligonucleotid
pool
differ
target
incub
isol
fraction
interest
specif
anim
tissu
cell
type
subcellular
fraction
contain
bind
complex
target
oligonucleotid
sequenc
partit
unbound
sequenc
amplifi
pcr
process
repeat
pool
enrich
targetspecif
sequenc
increas
specif
counter
select
introduc
prior
knowledg
deliveri
mechan
bind
target
deliveri
pathway
tissu
cell
surfac
barrier
unnecessari
crucial
type
tissu
cell
organel
use
process
specif
recogn
target
gener
aptam
select
aptam
use
differ
stage
nanorocket
design
tissu
penetr
cell
target
recognit
cellular
intern
appropri
linkag
aptam
stage
freeli
rotat
perform
function
cytosol
cleavabl
linker
pentano
spp
butyr
spdb
acidcleav
hydrazon
linker
lysosomespecif
releas
recognit
deliv
stage
nanorocket
remov
desir
time
point
reach
target
recognit
deliv
stage
nanorocket
cleav
degrad
cell
leav
cargo
oligo
chemic
modifi
resist
degrad
modifi
aptam
multistag
nanorocket
use
tissu
celltyp
cellular
compartmentspecif
deliveri
system
figur
term
diagnost
number
analyt
devic
introduc
past
year
improv
perform
simplifi
diagnost
procedur
afm
microfluid
capillari
electrophoresi
employ
coupl
aptam
high
specif
detect
afm
permit
assess
aptam
bind
affin
interact
visual
aptamertarget
complex
consid
step
forward
toward
realtim
aptam
monitor
futur
nanopor
sensor
nanoscal
pore
voltag
appli
across
incorpor
procedur
thu
allow
realtim
observ
bind
singlemolecul
detect
achiev
measur
current
disrupt
caus
molecul
electrophoret
driven
pore
aptamerprotein
target
bind
character
ion
blockad
level
bind
evalu
realtim
figur
aptam
cheap
manufactur
thermal
stabl
nonimmunogen
specif
target
harm
cell
tissu
minim
toxic
healthi
one
chemic
modifi
facilit
visual
absorpt
deliveri
due
specif
stabil
versatil
aptam
embodi
futur
diagnost
therapi
